Search
Descriptor English: Bufexamac
Descriptor Spanish: Bufexamac
Descriptor bufexamac
Scope note: Bencenoacetamida con propiedades antiinflamatorias, analgésicas y antipiréticas. Se puede administrar de forma tópica y por vía oral o rectal.
Descriptor Portuguese: Bufexamac
Descriptor French: Bufexamac
Entry term(s): Allergipuran
Bufal
Bufederm
Bufexamac ratiopharm
Bufexamac-ratiopharm
Bufexamacratiopharm
Droxaryl
Jomax
Malipuran
Paraderm
Parfenac
Windol
duradermal
p Butoxyphenylacethydroxamic Acid
p-Butoxyphenylacethydroxamic Acid
Tree number(s): D02.065.064.294.088
D02.092.570.394.150
D02.241.511.372.150
D02.455.426.559.389.048.088
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D002019
Scope note: A benzeneacetamide with anti-inflammatory, analgesic, and antipyretic action. It is administered topically, orally, or rectally.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Anti-Inflammatory Agents, Non-Steroidal
Registry Number: 4T3C38J78L
CAS Type 1 Name: Benzeneacetamide, 4-butoxy-N-hydroxy-
Previous Indexing: Hydroxamic Acids (1971-1974)
Phenylacetates (1971-1974)
Public MeSH Note: 91; was see under HYDROXAMIC ACIDS 1975-90
History Note: 91(75); was see under HYDROXAMIC ACIDS 1975-90
DeCS ID: 2048
Unique ID: D002019
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1991/01/01
Date of Entry: 1974/11/19
Revision Date: 2016/07/05
Bufexamac - Preferred
Concept UI M0003003
Scope note A benzeneacetamide with anti-inflammatory, analgesic, and antipyretic action. It is administered topically, orally, or rectally.
Preferred term Bufexamac
Entry term(s) p Butoxyphenylacethydroxamic Acid
p-Butoxyphenylacethydroxamic Acid
Bufal - Narrower
Concept UI M0465108
Preferred term Bufal
Bufederm - Narrower
Concept UI M0465110
Preferred term Bufederm
Bufexamac-ratiopharm - Narrower
Concept UI M0465111
Preferred term Bufexamac-ratiopharm
Entry term(s) Bufexamac ratiopharm
Bufexamacratiopharm
duradermal - Narrower
Concept UI M0465112
Preferred term duradermal
Jomax - Narrower
Concept UI M0465104
Preferred term Jomax
Entry term(s) Paraderm
Parfenac
Malipuran - Narrower
Concept UI M0465105
Preferred term Malipuran
Windol - Narrower
Concept UI M0465106
Preferred term Windol
Allergipuran - Narrower
Concept UI M0465107
Preferred term Allergipuran
Droxaryl - Narrower
Concept UI M0351233
Preferred term Droxaryl



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey